Am J Perinatol 2020; 37(05): 497-502
DOI: 10.1055/s-0039-1683863
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

The Utility of Soluble CD14 Subtype in Early Diagnosis of Culture-Proven Early-Onset Neonatal Sepsis and Prediction of Outcome

Ghada I. Gad
1   Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt
,
Dina M. Shinkar
1   Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt
,
Manal M. Kamel El-Din
2   Department of Clinical Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt
,
Hoda M. Nagi
3   Egyptian Ministry of Health, Cairo, Egypt
› Author Affiliations
Further Information

Publication History

30 August 2018

05 February 2019

Publication Date:
21 March 2019 (online)

Abstract

Objective This study aimed to evaluate soluble cluster of differentiation 14 subtype (sCD14-ST), also named presepsin, as an early marker for the diagnosis of culture-proven early-onset sepsis (EOS) in neonates and to assess its relation to disease severity and mortality.

Study Design Out of 60 neonates with risk factors of EOS, 31 neonates were diagnosed as having culture-proven EOS. They were compared with 20 nonseptic controls. We obtained blood samples on day 1 of life for sCD14-ST measurement and sepsis screening. Blood samples were repeated on day 3 in EOS neonates.

Results sCD14-ST was significantly higher in EOS neonates than controls (p < 0.001). Neonates who later developed septic shock had significantly higher day 1 sCD14-ST level than those who did not (p < 0.001). Furthermore, neonates who died had significantly higher day 1 sCD14-ST than survivors (p < 0.001). On day 3, there was a significant decline in sCD14-ST levels than initial levels among survivors. There was a significant positive correlation between day 1 sCD14-ST level and Tollner's sepsis severity score.

Conclusion sCD14-ST could be used as a powerful diagnostic and prognostic marker of EOS. Its quantitative measurement at birth could be a good predictor of sepsis severity and mortality.

 
  • References

  • 1 Khair KB, Rahman MA, Sultana T. , et al. Role of hematologic scoring system in early diagnosis of neonatal septicemia. Bangabandhu Sheikh Mujib Medical University J 2010; 3: 62-67
  • 2 Shehab El-Din EM, El-Sokkary MMA, Bassiouny MR, Hassan R. Epidemiology of neonatal sepsis and implicated pathogens: a study from Egypt. BioMed Res Int 2015; 2015: 509484
  • 3 van Herk W, Stocker M, van Rossum AMC. Recognising early onset neonatal sepsis: an essential step in appropriate antimicrobial use. J Infect 2016; 72 (Suppl): S77-S82
  • 4 Brocklehurst P, Farrell B, King A. , et al; INIS Collaborative Group. Treatment of neonatal sepsis with intravenous immune globulin. N Engl J Med 2011; 365 (13) 1201-1211
  • 5 Paolucci M, Landini MP, Sambri V. How can the microbiologist help in diagnosing neonatal sepsis?. Int J Pediatr 2012; 2012: 120139
  • 6 Streimish I, Bizzarro M, Northrup V. , et al. Neutrophil CD64 as a diagnostic marker in neonatal sepsis. Pediatr Infect Dis J 2012; 31 (07) 777-781
  • 7 Choo YK, Cho HS, Seo IB, Lee HS. Comparison of the accuracy of neutrophil CD64 and C-reactive protein as a single test for the early detection of neonatal sepsis. Korean J Pediatr 2012; 55 (01) 11-17
  • 8 Topcuoglu S, Arslanbuga C, Gursoy T. , et al. Role of presepsin in the diagnosis of late-onset neonatal sepsis in preterm infants. J Matern Fetal Neonatal Med 2016; 29 (11) 1834-1839
  • 9 Mathews AA, Appalaraju B, Siddharthet K. Impact of blood cultures drawn by phlebotomy on contamination rates and health care costs in the ICU ward of a tertiary hospital. Asian Journal of Biomedical and Pharmaceutical Sciences. 2013; 3: 72-77
  • 10 Wu TW, Tabangin M, Kusano R, Ma Y, Ridsdale R, Akinbi H. The utility of serum hepcidin as a biomarker for late-onset neonatal sepsis. J Pediatr 2013; 162 (01) 67-71
  • 11 Urbonas V, Eidukaitė A, Tamulienė I. The predictive value of soluble biomarkers (CD14 subtype, interleukin-2 receptor, human leucocyte antigen-G) and procalcitonin in the detection of bacteremia and sepsis in pediatric oncology patients with chemotherapy-induced febrile neutropenia. Cytokine 2013; 62 (01) 34-37
  • 12 Shirakawa K, Naitou K, Hirose J, Takahashi T, Furusako S. Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients. Clin Chem Lab Med 2011; 49 (05) 937-939
  • 13 Mussap M, Puxeddu E, Burrai P. , et al. Soluble CD14 subtype (sCD14-ST) presepsin in critically ill preterm newborns: preliminary reference ranges. J Matern Fetal Neonatal Med 2012; 25 (Suppl. 05) 51-53
  • 14 Caffrey Osvald E, Prentice P. NICE clinical guideline: antibiotics for the prevention and treatment of early-onset neonatal infection. Arch Dis Child Educ Pract Ed 2014; 99 (03) 98-100
  • 15 Modi N, Doré CJ, Saraswatula A. , et al. A case definition for national and international neonatal bloodstream infection surveillance. Arch Dis Child Fetal Neonatal Ed 2009; 94 (01) F8-F12
  • 16 Goldstein B, Giroir B, Randolph A. ; International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005; 6 (01) 2-8
  • 17 Apgar V. A proposal for a new method of evaluation of the newborn infant. Curr Res Anest Anal 1953; 32 (04) 260-267
  • 18 Töllner U. Early diagnosis of septicemia in the newborn. Clinical studies and sepsis score. Eur J Pediatr 1982; 138 (04) 331-337
  • 19 Montaldo P, Rosso R, Santantonio A, Chello G, Giliberti P. Presepsin for the detection of early-onset sepsis in preterm newborns. Pediatr Res 2017; 81 (02) 329-334
  • 20 Abd Elmouttaleb AT, Aly HA, Bayomy EM. , et al. Plasma procalcitonin and proadrenomedullin concentrations as predictive markers for early onset neonatal sepsis. Am J Biochem 2016; 6: 6-15
  • 21 Pugni L, Pietrasanta C, Milani S. , et al. Presepsin (soluble cd14 subtype): reference ranges of a new sepsis marker in term and preterm neonates. PLoS One 2015; 10 (12) e0146020
  • 22 Xiao T, Chen LP, Zhang LH. , et al. The clinical significance of sCD14-ST for blood biomarker in neonatal hematosepsis: a diagnostic accuracy study. Medicine (Baltimore) 2017; 96 (18) e6823
  • 23 Rashwan NI, Hassan MH, Mohey El-Deen ZM, Ahmed AE. Validity of biomarkers in screening for neonatal sepsis - a single center -hospital based study. Pediatr Neonatol 2018
  • 24 Mostafa RM, Kholouss SM, Zakaria N. , et al. Detection of presepsin and surface cd14 as a biomarker for early diagnosis of neonatal sepsis. J Am Sci 2015; 11 (10) 104-116
  • 25 Mussap M, Puxeddu E, Puddu M. , et al. Soluble CD14 subtype (sCD14-ST) presepsin in premature and full term critically ill newborns with sepsis and SIRS. Clin Chim Acta 2015; 451 (Pt A): 65-70
  • 26 Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010; 11 (05) 373-384
  • 27 Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011; 34 (05) 637-650
  • 28 Hedegaard SS, Wisborg K, Hvas AM. Diagnostic utility of biomarkers for neonatal sepsis--a systematic review. Infect Dis (Lond) 2015; 47 (03) 117-124
  • 29 Simonsen KA, Anderson-Berry AL, Delair SF, Davies HD. Early-onset neonatal sepsis. Clin Microbiol Rev 2014; 27 (01) 21-47
  • 30 Stojewska M, Behrendt J, Szymanska A. , et al. Diagnostic value of presepsin (Scd14-St Subtype) evaluation in the detection of severe neonatal infections. Int J Res Stud Biosci 2015; 3: 110-116
  • 31 Mussap M, Puxeddu E, Puddu M. , et al. Soluble CD14 subtype (sCD14-ST) presepsin in premature and full term critically ill newborns with sepsis and SIRS. Clin Chim Acta 2015; 451 (Pt A): 65-70
  • 32 Blanco A, Solis G, Arranz E, Coto GD, Ramos A, Telleria J. Serum levels of CD14 in neonatal sepsis by gram-positive and gram-negative bacteria. Acta Paediatr 1996; 85 (06) 728-732
  • 33 Behnes M, Bertsch T, Lepiorz D. , et al. Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment. Crit Care 2014; 18 (05) 507-520
  • 34 Spanuth E, Ebelt H, Ivandic B. , et al. Diagnostic and prognostic value of presepsin (soluble cd14 subtype) in emergency patients with early sepsis using the new assay PATHFAST Presepsin. Presented in the 21st International Congress of Clinical Chemistry and Laboratory Medicine, IFCC-World Lab – Euro Med Lab, Berlin, May 15–19, 2011